A. Bilici Et Al. , "PLASMA M30 AND M65 LEVELS IN PATIENTS WITH ADVANCED GASTRIC CANCER: IS THERE AN IMPACT ON SURVIVAL OF PATIENTS?," 35th European-Society-for-Medical-Oncology (ESMO) Congress , vol.21, Milan, Italy, pp.48, 2010
Bilici, A. Et Al. 2010. PLASMA M30 AND M65 LEVELS IN PATIENTS WITH ADVANCED GASTRIC CANCER: IS THERE AN IMPACT ON SURVIVAL OF PATIENTS?. 35th European-Society-for-Medical-Oncology (ESMO) Congress , (Milan, Italy), 48.
Bilici, A., Ustaalioglu, B. B. O., Orcun, A., Ercan, S., Seker, M., Kefeli, U., ... Yilmaz, B. E.(2010). PLASMA M30 AND M65 LEVELS IN PATIENTS WITH ADVANCED GASTRIC CANCER: IS THERE AN IMPACT ON SURVIVAL OF PATIENTS? . 35th European-Society-for-Medical-Oncology (ESMO) Congress (pp.48). Milan, Italy
Bilici, A. Et Al. "PLASMA M30 AND M65 LEVELS IN PATIENTS WITH ADVANCED GASTRIC CANCER: IS THERE AN IMPACT ON SURVIVAL OF PATIENTS?," 35th European-Society-for-Medical-Oncology (ESMO) Congress, Milan, Italy, 2010
Bilici, A. Et Al. "PLASMA M30 AND M65 LEVELS IN PATIENTS WITH ADVANCED GASTRIC CANCER: IS THERE AN IMPACT ON SURVIVAL OF PATIENTS?." 35th European-Society-for-Medical-Oncology (ESMO) Congress , Milan, Italy, pp.48, 2010
Bilici, A. Et Al. (2010) . "PLASMA M30 AND M65 LEVELS IN PATIENTS WITH ADVANCED GASTRIC CANCER: IS THERE AN IMPACT ON SURVIVAL OF PATIENTS?." 35th European-Society-for-Medical-Oncology (ESMO) Congress , Milan, Italy, p.48.
@conferencepaper{conferencepaper, author={A. Bilici Et Al. }, title={PLASMA M30 AND M65 LEVELS IN PATIENTS WITH ADVANCED GASTRIC CANCER: IS THERE AN IMPACT ON SURVIVAL OF PATIENTS?}, congress name={35th European-Society-for-Medical-Oncology (ESMO) Congress}, city={Milan}, country={Italy}, year={2010}, pages={48} }